MENU
OVID
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ovid Therapeutics (OVID) Ownership - Who owns Ovid Therapeutics?
Industry: @Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
441 Ninth Avenue
Phone
+1 646 661-7661
Employees
40
Web
https://www.ovidrx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
72.43M
P/E Ratio
N/A
Total Cash
62.71M
Projected Growth
N/A
Total Debt
15.08M
Revenue
631.7K
Risk (Beta)
-0.38
Dividend Yield
N/A
Total Cash/Share
0.88
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
OVID
Capitalization
72.4M
P/E Ratio
N/A
Risk (Beta)
-0.38
Dividend Yield
N/A
Total Cash
62.7M
Total Cash/Share
0.88
Total Debt
15.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
632K
ROE
N/A
Book Value
76.3M
P/B Ratio
0.95
Cash Flow
N/A
Earnings
-0.46
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
71K
Current Ratio
5.66
Current Revenue Per Employee
6920.00
Dividends Per Share - Security
N/A
EBITDA
-67.73M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-28.55
Shares Held By Institutions
46.4M
Shares Outstanding - Current
71M
Total Liabilities
26.4M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-67.081
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Provides medicines to children and adults with neurological disorders
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
441 Ninth Avenue
Phone
+1 646 661-7661
Employees
40
Web
https://www.ovidrx.com